Here are the 424B prospectus supplements from Odyssey Health Inc (ODYY) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow ODYY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ODYY filings page.
Odyssey Health Inc. is registering 18,000,000 shares of common stock for resale by Mast Hill Fund, L.P. These shares relate to the conversion of a $2,262,000 Maintenance Agreement convertible promissory note, a $500,000 purchase agreement note, and the exercise of a warrant for 1,538,461 shares, all convertible or exercisable at a 15% discount to the lowest volume weighted average price over the prior 10 trading days. Odyssey will not receive proceeds from Mast Hill Fund’s resale of these shares, but may receive up to $25,000,000 in gross proceeds over time from selling common stock to Mast Hill Fund under a Securities Purchase Agreement, plus warrant exercise proceeds. As of December 17, 2025, Odyssey had 99,853,763 common shares outstanding, and if all 18,000,000 registered shares were issued they would represent about 15% of the then-outstanding stock. The company warns that these arrangements may cause substantial dilution and that large or anticipated resales could put pressure on its OTCQB-traded share price.